# FDA Inspection 1309604 - Humacyte Global Inc - February 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/humacyte-global-inc/05cdb2fd-560f-42ac-85ea-5e4293727de1
Source feed: FDA_Inspections

> FDA Inspection 1309604 for Humacyte Global Inc on February 12, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309604
- Company Name: Humacyte Global Inc
- Inspection Date: 2026-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1309604 - 2026-02-12](https://www.keypedia.com/records/fda_inspections/humacyte-global-inc/e613c995-3199-4465-bf03-4ae36e6bc650)
- [FDA Inspection 1242447 - 2024-06-17](https://www.keypedia.com/records/fda_inspections/humacyte-global-inc/a90e305a-d957-4a94-933c-b9214139b0fe)

Company: https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f